Cite
Maubant S, Tahtouh T, Brisson A, et al. LRP5 regulates the expression of STK40, a new potential target in triple-negative breast cancers. Oncotarget. 2018;9(32):22586-22604doi: 10.18632/oncotarget.25187.
Maubant, S., Tahtouh, T., Brisson, A., Maire, V., Némati, F., Tesson, B., Ye, M., Rigaill, G., Noizet, M., Dumont, A., Gentien, D., Marty-Prouvost, B., de Koning, L., Mahmood, S. F., Decaudin, D., Cruzalegui, F., Tucker, G. C., Roman-Roman, S., & Dubois, T. (2018). LRP5 regulates the expression of STK40, a new potential target in triple-negative breast cancers. Oncotarget, 9(32), 22586-22604. https://doi.org/10.18632/oncotarget.25187
Maubant, Sylvie, et al. "LRP5 regulates the expression of STK40, a new potential target in triple-negative breast cancers." Oncotarget vol. 9,32 (2018): 22586-22604. doi: https://doi.org/10.18632/oncotarget.25187
Maubant S, Tahtouh T, Brisson A, Maire V, Némati F, Tesson B, Ye M, Rigaill G, Noizet M, Dumont A, Gentien D, Marty-Prouvost B, de Koning L, Mahmood SF, Decaudin D, Cruzalegui F, Tucker GC, Roman-Roman S, Dubois T. LRP5 regulates the expression of STK40, a new potential target in triple-negative breast cancers. Oncotarget. 2018 Apr 27;9(32):22586-22604. doi: 10.18632/oncotarget.25187. eCollection 2018 Apr 27. PMID: 29854300; PMCID: PMC5978250.
Copy
Download .nbib